Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 1/11/16  and contains information from public web pages and contributions from the ZoomInfo community.

Mr. Duane M. DeSisto

Wrong Duane M. DeSisto?

President and Chief Executive Off...

Phone: (661) ***-****  HQ Phone
Email: d***@***.com
Local Address:  United States
MannKind Corporation
28903 North Ave Paine
Valencia , California 91355
United States

Company Description: MannKind Corporation (MannKind) is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases,...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • Master of Business Administration
    Bryant College
  • Bachelor of Science
    Providence College
185 Total References
Web References
Giant leap: The new chief executive ...
www.latimes.com, 11 Jan 2016 [cached]
Giant leap: The new chief executive of Valencia drug maker MannKind, Duane DeSisto, will likely face a lot of questions about the future of the company and its inhalable insulin treatment Afrezza when he appears Tuesday at an investor conference in San Francisco. Last week, French pharmaceutical giant Sanofi told MannKind it would stop selling and marketing the drug after nearly a year of disappointing sales. DeSisto became CEO on Jan. 5.
MannKind Corporation (MNKD) Names ...
www.biospace.com, 29 Dec 2015 [cached]
MannKind Corporation (MNKD) Names Duane DeSisto as President and CEO     12/29/2015 MannKind Corporation Names Duane DeSisto as President and CEO
...
MannKind Corporation (MNKD) Names Duane DeSisto as President and CEO
...
MannKind Announces Appointment of Duane DeSisto as Chief Executive Officer
VALENCIA, Calif., Dec. 23, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) and (TASE:MNKD) today announced the appointment of Duane M. DeSisto as its President and Chief Executive Officer, effective January 5, 2016, replacing Alfred Mann who has served as interim CEO since November 19, 2015.
...
Mr. DeSisto was also appointed to fill an existing vacancy on the board of directors, effective January 5, 2016.
Previously, Mr. DeSisto served as the Chief Executive Officer and President of Insulet Corporation, a medical device company, from 2003 to 2014. From 2002 to 2003, he served as the President, Chief Financial Officer and Acting Chief Executive Officer of Insulet Corporation and, from 2001 to 2002, he served as the Chief Financial Officer and Treasurer of Insulet Corporation.
"Duane is a respected industry veteran with a strong track record of developing and commercializing disruptive technology for the management of diabetes," said Alfred Mann, Executive Chairman of MannKind.
...
"Duane's experience will be instrumental as we seek to enhance the commercial opportunity for Afrezza® and pursue additional product opportunities within our pipeline. We are excited to welcome Duane to the team and look forward to his leadership."
"I am thrilled to be joining MannKind and I look forward to working with the Board and leadership team to help Afrezza realize its full potential," said Mr. DeSisto. "MannKind has world-class pharmaceutical technology that has the potential to address a large number of unmet medical needs, and I am excited by the opportunities at MannKind for creating significant value for our shareholders."
From 1999 to 2001, Mr. DeSisto served in various positions at PaperExchange.com, Inc., a business solutions provider for the pulp and paper industry, including as President, Chief Executive Officer and Chief Financial officer. From 1995 to 1999, Mr. DeSisto served as the Chief Financial Officer of FGX International Holdings Limited (formerly AAI-Foster Grant, Inc.), an accessories wholesaler, where he had overall responsibility for the accounting, information technology and human resource departments. From 1986 to 1995, Mr. DeSisto served as the chief financial officer of ZOLL Medical Corporation, a medical device company specializing in noninvasive resuscitation devices and related software solutions. Mr. DeSisto earned a Bachelor of Science from Providence College and a Master of Business Administration from Bryant College.
...
This press release contains forward-looking statements that involve risks and uncertainties, including statements regarding Mr. DeSisto's expected contributions to MannKind, the potential of Afrezza and MannKind's technology platform and MannKind's future development plans.
OmniPod Insulin Management System - Investor Relations - Board of Directors
phx.corporate-ir.net, 13 Nov 2011 [cached]
Duane DeSisto President, Chief Executive Officer and Director
Duane DeSisto has served as President, Chief Executive Officer and Director of Insulet since 2003. Previously, he served as the Company's acting Chief Executive Officer, Chief Financial Officer and Treasurer. Prior to joining Insulet, Mr. DeSisto was with PaperExchange.com, Inc., a business solutions provider for the pulp and paper industry, serving in various positions including President, Chief Executive Office and Chief Financial Officer. Previously, Mr. DeSisto served as Chief Financial Officer of FGX International Holdings Limited (formerly AAI-Foster Grant, Inc.), an accessories wholesaler. From 1986 to 1995, Mr. DeSisto served as Chief Financial Officer of ZOLL Medical Corporation, a medical device company. Mr. DeSisto currently serves on the board of directors of LeMaitre Vascular, Inc. He earned a Bachelor of Science from Providence College and a Master of Business Administration from Bryant College.
LeMaitre Vascular - Investor Relations - Corporate Governance - Biography
ir.lemaitre.com, 14 Sept 2007 [cached]
Duane M. DeSisto
LeMaitre Vascular - Investor Relations - Corporate Governance - Biography
...
Duane M. DeSistoBoard Director
Duane has served as a member of our board of directors since 2006.Since 2001, Mr. DeSisto has served as the President and Chief Executive Officer of Insulet Corporation, which develops and markets medical devices for the treatment of diabetes.Mr. DeSisto was the Chief Financial Officer of PaperExchange, a privately held wood pulp and paper internet marketplace from 1999 to 2001.Before that, he served as Chief Financial Officer of AAI-Foster Grant.In 1992, Mr. DeSisto served as Chief Financial Officer of Zoll Medical during its initial public offering.Mr. DeSisto holds a B.S. from Providence College and an M.B.A. from Bryant College.
Duane DeSisto ...
investors.insulet.com, 18 June 2015 [cached]
Duane DeSisto
Other People with the name "DeSisto":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.